Warren Davis
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Cancer Risks and Factors
- Cancer Research top 5%
Papers in
-
- Peroxisome Proliferator-Activated Receptors 8
- Molecular Biology Techniques and Applications 7
- Oncology 41
- Drug Transport and Resistance Mechanisms 16
- Cancer Risks and Factors 10
- Co-authors
- Kenneth D. Tew (11 shared papers)Christine B. Ambrosone (46 shared papers)Richard M. Schultz (6 shared papers)Ze’ev A. Ronai (1 shared paper)Mary Nesline (7 shared papers)Susan E. McCann (11 shared papers)Paul A. De Sousa (2 shared papers)Song Yao (30 shared papers)
- Journals
- Cancer Research (8 papers)Cancer Epidemiology Biomarkers & Prevention (6 papers)Journal of Clinical Oncology (4 papers)Breast Cancer Research and Treatment (4 papers)PLoS ONE (4 papers)
- Partner nations
- United StatesUnited KingdomSouth Korea
In The Last Decade
Warren Davis
98 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 139
- Oncology 938
- Cancer Research 443
- Molecular Biology 1.6k
- Genetics 595
- Pathology and Forensic Medicine 347
Countries citing papers authored by Warren Davis
This map shows the geographic impact of Warren Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Warren Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Warren Davis more than expected).
Fields of papers citing papers by Warren Davis
This network shows the impact of papers produced by Warren Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Warren Davis. The network helps show where Warren Davis may publish in the future.
Co-authors
The 25 scholars most cited alongside Warren Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 301 | |
| 2 | 2009 | 160 | |
| 3 | 1996 | 141 | |
| 4 | 2008 | 119 | |
| 5 | 2016 | 112 | |
| 6 | 2005 | 111 | |
| 7 | 2008 | 107 | |
| 8 | 2016 | 95 | |
| 9 | 1999 | 91 | |
| 10 | 2011 | 88 | |
| 11 | 1996 | 87 | |
| 12 | 2011 | 83 | |
| 13 | Cloning and characterization of human adenosine 5'-triphosphate-binding cassette, sub-family A, transporter 2 (ABCA2). | 2001 | 73 |
| 14 | 2012 | 71 | |
| 15 | 2020 | 59 | |
| 16 | 2011 | 58 | |
| 17 | 2004 | 57 | |
| 18 | 2006 | 56 | |
| 19 | 2000 | 55 | |
| 20 | 1998 | 51 |
About Warren Davis
Warren Davis is a scholar working on Molecular Biology, Oncology, Genetics, Cancer Research and Surgery, having authored 100 papers that have together received 3.3k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (16 papers), Cholesterol and Lipid Metabolism (12 papers), Estrogen and related hormone effects (11 papers), Cancer Risks and Factors (10 papers), Peroxisome Proliferator-Activated Receptors (8 papers), Molecular Biology Techniques and Applications (7 papers), Vitamin D Research Studies (6 papers) and Breast Cancer Treatment Studies (6 papers). The work is most often cited by research in Oncology (938 citations), Cancer Research (443 citations), Molecular Biology (1.6k citations), Genetics (595 citations) and Pathology and Forensic Medicine (347 citations). Warren Davis has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Kenneth D. Tew, Christine B. Ambrosone, Richard M. Schultz, Ze’ev A. Ronai, Mary Nesline, Susan E. McCann, Paul A. De Sousa, Song Yao, Chi-Chen Hong and Jeremy Saklatvala. Their work appears in journals such as Cancer Research, Cancer Epidemiology Biomarkers & Prevention, Journal of Clinical Oncology, Breast Cancer Research and Treatment and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.